Abstract Objective Develop a cerebrospinal fluid biomarker signature for mild Alzheimer's disease (AD) in Alzheimer's Disease Neuroimaging Initiative (ADNI) subjects. Methods Amyloid‐β 1 to 42 peptide (Aβ 1–42 ), total tau (t‐tau), and tau phosphorylated at the threonine 181 were measured in (1) cer...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!